In line with such observations a recent meta-analysis confirmed the favorable outcome of statins on several clinical parameters of RA such as erythrocyte sedimentation rate, CRP, tender, and swollen joint count, highlighting the potential dual benefit of statins on both joint and vascular inflammation (79). The gene discussed is CRP; the disease is rheumatoid arthritis.